Oncotarget

Research Papers:

THIS IS A TEST PAPER - NOT FOR PRODUCTION

PDF  |  Full Text  |  How to cite

DOI pending

Marina Baretti1, Qingfeng Zhu2, Wei Fu3, Jeffrey Meyer4, Hao Wang3, Robert A. Anders2 and Nilofer S. Azad1

1 Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA

2 Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA

3 Division of Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA

4 Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA

Correspondence to:

Marina Baretti, email: [email protected]

Keywords: programmed death ligand 1; tumor-infiltrating lymphocytes; immune checkpoints; colorectal cancer; neoadjuvant chemoradiotherapy

Received: March 09, 2022     Accepted: June 28, 2022     Published: PUBLISHED_DATE

Copyright: © 2022 Baretti et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

ABSTRACT

THIS IS A TEST PAPER - NOT FOR PRODUCTION

resubmission test